Funding

Mediar Therapeutics

United States · Biotech · Healthtech

Develops therapies to halt fibrosis in multiple organ systems

Visit mediartx.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series B$76MAlexandria Real Estate Trust (ARE) — Role not disclosedAmplitude Ventures — Role not disclosedAsahi Kasei Pharma Ventures — Role not disclosedICG — Role not disclosedLongwood Fund — Role not disclosed

Investors

Alexandria Real Estate Trust (ARE)Series BAmplitude VenturesSeries BAsahi Kasei Pharma VenturesSeries BICGSeries BLongwood FundSeries B

Coverage

Jan 7, 2026Mediar Therapeutics · Series B

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcesmediartx.com ↗